Tasquinimod
- Generic Name
- Tasquinimod
- Drug Type
- Small Molecule
- Chemical Formula
- C20H17F3N2O4
- CAS Number
- 254964-60-8
- Unique Ingredient Identifier
- 756U07KN1R
- Background
The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts
- Indication
Investigated for use/treatment in prostate cancer.
A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- Active Biotech AB
- Target Recruit Count
- 6
- Registration Number
- NCT01048203
- Locations
- 🇸🇪
JJ Berzelius Clinical Research Center AB, Berzelius Science Park, Linköping, Sweden
Efficacy Study of ABR-215050 to Treat Prostate Cancer
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2015-10-26
- Lead Sponsor
- Active Biotech AB
- Target Recruit Count
- 206
- Registration Number
- NCT00560482
- Locations
- 🇺🇸
Staten Island Urological Research, PC, Staten Island, New York, United States
🇺🇸Southeastern Resarch Group, Inc., Tallahassee, Florida, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath